Pages

Tuesday, July 19, 2022

Novartis no longer expects earnings decline at under-review Sandoz unit https://ift.tt/q7yIZPL

The pharma major also said it was now targeting $1.5 billion in savings from an ongoing group-wide cost cutting scheme, where it had previously seen savings of up to $1 billion by 2024.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/nSF9pzU

No comments:

Post a Comment